Aono Y, Sasaki Y, Imaoka S, Nakano H, Furukawa H, Ishikawa O, Kabuto T, Kameyama M, Hiratsuka M, Ohigashi H
Dept. of Surgery, Center for Adult Diseases, Osaka.
Gan To Kagaku Ryoho. 1995 Sep;22(11):1660-3.
We encountered a 53-year-old male patient with advanced hepatocellular carcinoma (HCC) uncontrolled by transcatheter arterial embolization (TAE). Numerous tumors with a huge one occupying the lateral segment were shown on abdominal ultrasonogram, computed tomogram and angiogram. The first TAE was ineffective for the lesions because of the development of collateral feeders. Lateral segmentectomy and, "wrapping therapy" for the liver remnant were performed, and catheters were put both into the hepatic artery and into the portal vein for regional chemotherapy. About a year after the procedure, anticancer drugs were administered. When tumor stains were found by following computed tomography or angiography, TAE was performed. The patient has survived for five years and four months. The combination of several kinds of treatment serves to improve the prognosis of patients with advanced HCC if the liver function is preserved.
我们遇到了一名53岁的男性晚期肝细胞癌（HCC）患者，经肝动脉栓塞术（TAE）治疗后病情仍未得到控制。腹部超声、计算机断层扫描和血管造影显示有大量肿瘤，其中一个巨大肿瘤占据了肝外侧段。由于侧支供血的出现，首次TAE对病变无效。我们进行了肝外侧段切除术及对肝残余部分的“包裹疗法”，并将导管分别置入肝动脉和门静脉进行区域化疗。术后约一年开始给予抗癌药物。当通过后续的计算机断层扫描或血管造影发现肿瘤染色时，即进行TAE。该患者已存活五年零四个月。如果肝功能得以保留，多种治疗方法联合应用有助于改善晚期HCC患者的预后。
